Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Effects of Rapid-Release Aspirin and NHP-544C on Prostacyclin Production
NCT02189122Phase 1Completed
- Sponsor
- Vanderbilt University
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cardiovascular diseases (CVD) comparing Group 1: Aspirin/Placebo with Group 2: NHP-544C/Placebo (2 arms). Primary endpoints: Urine Thromboxane Concentrations and Urine Prostacyclin Concentrations. Started Jul 2014; status: completed.
02
Drugs
NHP544C
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT02189122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02189122.